Neurolymphomatosis - Rare presentation in non-hodgkin's lymphoma: The role of 18 F-fluorodeoxyglucose positron-emission tomography and computerized tomography imaging
Neurolymphomatosis (NLS) is infiltration of lymphoma cells into the peripheral or cranial nervous system and is a rare manifestation of non-Hodgkin lymphoma (NHL). Nerve biopsy is considered as the gold standard for diagnosis but not a preferred choice, and magnetic resonance imaging has lower reported sensitivity. 18F-Fluorodeoxyglucose (18FDG) positron-emission tomography and computerized tomography (PET/CT) has a higher sensitivity for diagnosing and assessing the neurological and nonneurological metabolic tumor volume and response evaluation to therapy. We present the case of a lady, known to have NHL in remission. She presented with a short history of severe pain and weakness of the right lower limb. Baseline and interim 18FDG PET/CT played a crucial role in diagnosing and assessing the extent of NLS and nonneurological disease burden and also in evaluation of response to treatment.
World Journal of Nuclear Medicine
Zaman, M. U.,
Zaman, S. U.
(2020). Neurolymphomatosis - Rare presentation in non-hodgkin's lymphoma: The role of 18 F-fluorodeoxyglucose positron-emission tomography and computerized tomography imaging. World Journal of Nuclear Medicine, 19(2), 159-161.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_radiol/467